Methods of detecting human IL-21
US11267882B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2017 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Aug 9, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/104
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided are antibodies, or an antigen-binding fragment thereof, that binds human IL-21, These antibodies are useful in immunoassays of IL-21 levels, and/or in vivo, ex vivo or in vitro immunochemical and other imaging methods for determining the presence of IL-21 and/or quantifying IL-21 levels, and for diagnostic, prognostic and predictive purpose, and or optimizing therapeutic regimens in patients in which IL-21 signaling is implicated in pathogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.